Back
HF 2024 Premium Access

Correlation of sST2 with chosen biochemical parameters and influence on prognosis in patients hospitalized due to HFrEF.

Session: Chronic heart failure - pathophysiology and mechanisms 3
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker: Doctor M. Dudek (Poznan, PL)
Event: Heart Failure 2024

Congress Presentation

About the speaker

Doctor Magdalena Dudek

Poznan University of Medical Sciences, Poznan (Poland)
0 follower

7 more presentations in this session

Safety and effect of EMPAGLIFOZIN in patients with HF reduced LVEF in renal function replacement therapy. Adjustments needed for real life

Speaker: Doctor R. Rascon Sabido (Veracruz, MX)

Access
Abstract
Slides
Thumbnail

Long-term hydroxychloroquine exposure impairs the left ventricular longitudinal strain

Speaker: Doctor R. Didier (Dijon, FR)

Access
Abstract
Slides
Thumbnail

Exrecise capacity dynamics in non-hodgkin lymphoma patients

Speaker: Doctor D. Bursacovschi (Chisinau, MD)

Access
Abstract
Slides
Thumbnail

The impact of antitumor therapy on cardiac systolic function in patients with non-hodgkin lymphoma

Speaker: Doctor D. Bursacovschi (Chisinau, MD)

Access
Abstract
Slides
Thumbnail

Implications of pulmonary artery pressures during both heart failure and non heart failure hospitalizations for subsequent hospitalization events

Speaker: Doctor M. Costanzo (Naperville, US)

Access
Abstract
Slides
Thumbnail

Access the full session

Chronic heart failure - pathophysiology and mechanisms 3

Speakers: Doctor M. Dudek, Doctor R. Rascon Sabido, Doctor R. Didier, Doctor D. Bursacovschi, Doctor D. Bursacovschi...
Access
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb